Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Anna Cruceta
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Written informed consent
Histologically confirmed diagnosis of melanoma, breast cancer or head and neck cancer and candidate for surgical resection with lymph node mapping being a part of the surgical plan.
At least 18 years of age at the time of consent.
The subject is clinically node negative (cN0) at the time of screening.
In Melanoma Patients
* Diagnosis of primary melanoma with sentinel node indication ( \>0.8 mm Breslow thickness; clinically negative lymph nodes)
In Breast Cancer Patients
* T1-T2 N0 breast cancer.
* Patients with pure ductal carcinoma in situ (DCIS) if lymph node biopsy is part of the surgical plan.
In Oral cavity tumors patients
* T1-T2 N0 oral cavity squamous cell carcinoma
You may not be if
Pregnancy or lactation
Clinical or radiological evidence of metastatic cancer including palpably abnormal or enlarged lymph nodes
Patients that have had preoperative chemotherapy, immunotherapy or radiation therapy
Patients who have undergone node basin surgery of any type or radiation to the nodal basin(s) potentially draining the primary tumor
Patients who have undergone a wide excision for their tumor or complex reconstruction (rotation, free flap or skin graft of any type).
Clareo Health | Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
